About levocarnitine
Carnitine replacement agent
Used for
- Treats carnitine deficiency, including deficiency associated with dialysis or inherited disorders.
- Used for acute metabolic crises in certain inherited disorders of fatty-acid oxidation.
Usual adult dose
Commonly 50 mg/kg intravenously, adjusted to the indication and clinical response; specialist regimens vary.
Usual dose in children
Commonly 50 mg/kg intravenously for deficiency or metabolic crises; specialist dosing varies by condition.
Common side effects
- Nausea, vomiting, or diarrhea
- Injection-site reactions
- Fishy body odor
- Seizures, particularly in people with seizure disorders
Important warnings
- Use under medical supervision; dosing depends on the cause and laboratory results.
- Rapid intravenous administration may cause flushing or low blood pressure.
- Seizures have been reported, including worsening in people with prior seizures.
- Some injectable formulations contain preservatives unsuitable for certain newborns.
Pregnancy
Use when clinically needed; human pregnancy data are limited, and untreated deficiency may also pose risks.
Breastfeeding
Human data are limited; treatment may be used when needed under medical supervision.
Interactions
- Warfarin: levocarnitine may increase anticoagulant effect; monitor clotting tests.
- May alter thyroid hormone requirements or laboratory results in people receiving thyroid treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.